Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.44 |
| ▸ | AMY2A | P04746 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LRAT | O95237 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 2/20 | 0.38 |
| ▸ | SI | P14410 | 2/20 | 0.38 |
| ▸ | FGF1 | P05230 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | GJA1 | P17302 | 1/20 | 0.37 |
| ▸ | GJB2 | P29033 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16362497 | 1.00 | LGALS8 (0.44) | LGALS8AMY2AMEN1LRATTRPV1 | |
| SCHEMBL8408100 | 1.00 | LGALS8 (0.44) | LGALS8AMY2AMEN1LRATTRPV1 | |
| SCHEMBL15235669 | 1.00 | LGALS8 (0.44) | LGALS8AMY2AMEN1LRATTRPV1 | |
| SCHEMBL16784536 | 1.00 | LGALS8 (0.44) | LGALS8AMY2AMEN1LRATTRPV1 | |
| SCHEMBL13990757 | 0.94 | MEN1 (0.49) | AMY2AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL13903853 | 0.94 | MEN1 (0.49) | AMY2AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL14639596 | 0.94 | MEN1 (0.49) | AMY2AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL17816417 | 0.94 | MEN1 (0.49) | AMY2AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL7150867 | 0.87 | LGALS8 (0.47) | LGALS8MEN1TSHRLMNAKDM4E | |
| SCHEMBL7150873 | 0.87 | LGALS8 (0.47) | LGALS8MEN1TSHRLMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024148030-A1 | KETO ACID BIOPOLYMERS AND POLYOL KETO ESTERS AND USES THEREOF | ATOSSA THERAPEUTICS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| US-10412960-B2 | Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-09-17 | — | — | US | disclosed |
| US-20170056297-A1 | MULTI-FUNCTIONAL MICRO AND NANOPARTICLES FOR USE IN ROOT CANAL THERAPIES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10412960-B2 | Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine | CD44, CD63, ALG1 | LGALS8 574/4885AMY2A 816/4885MEN1 1985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.